Results 211 to 220 of about 657,398 (291)

Nine‐Year Follow‐Up After M‐TEER for Secondary Mitral Regurgitation in a Patient With Cardiogenic Shock

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter edge‐to‐edge repair (TEER) has become an established therapeutic option for patients with severe secondary mitral regurgitation (SMR). While randomized trials and registry data have reported outcomes up to 5 years, longer follow‐up data remain scarce.
Tobias Reithmayer, Thomas J. Stocker, Ludwig T. Weckbach, Julia Novotny, Philipp M. Doldi, Hannah Kempton, Steffen Massberg, Michael Näbauer, Jörg Hausleiter, Lukas Stolz   +9 more
wiley   +1 more source

Wastewater-based surveillance for severe acute respiratory syndrome coronavirus 2 variants in Gwangju, Republic of Korea. [PDF]

Front Microbiol
Lee C, Park J, No JS, Kim J, Seo J, Kim D, Kim IH, Kim EJ.   +7 more
europepmc   +1 more source

Severe acute respiratory syndrome-associated coronavirus disease: (Week 49) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending December 9, 2023

Severe acute respiratory syndrome-associated coronavirus disease cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations.

core  

Living Microbial Drugs

Chemistry – A European Journal, EarlyView.
The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik, Nazlıcan Tunç, Senem Şen, Urartu Özgür Şafak Şeker   +3 more
wiley   +1 more source

Unveiling the hidden burden of COVID-19 in Brazil's obstetric population with severe acute respiratory syndrome: A machine learning model. [PDF]

PLoS One
Franco VF, Zaccara TA, Ferreira OS, da Costa RA, Rodrigues AS, Francisco RP.   +5 more
europepmc   +1 more source

Severe acute respiratory syndrome-associated coronavirus disease: (Week 41) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending October 14, 2023

Severe acute respiratory syndrome-associated coronavirus disease cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations.

core  

Membrane‐Permeable Nucleoside T‐1106 Diphosphate and Triphosphate Analogues as Antiviral Pronucleotides

Chemistry – A European Journal, EarlyView.
Favipiravir (T‐705) and the non‐fluorinated counterpart (T‐1106) are antiviral agents that inhibit the RNA‐dependent RNA polymerase (RdRp) of various RNA viruses. The antiviral efficacy of nucleoside analogues is strongly dependent on their intracellular activation by cellular kinases to produce their corresponding triphosphate metabolites (T‐705‐RTP ...
Chris Meier, Duan Li, Leentje Persoons, Graciela Andrei, Robert Snoeck, Dominique Schols, Lieve Naesens, Xiao Jia   +7 more
wiley   +1 more source

Efficacy and safety of remdesivir for patients with severe acute respiratory syndrome coronavirus 2 infection: A systematic review of randomized controlled trials.

Indian J Pharmacol
Meena J, Agarwal A, Sandhu A, Pradhan P, Singh M.   +4 more
europepmc   +1 more source

Seroepidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Blood Donors from Western Romania, August-September 2023. [PDF]

Microorganisms
Olariu TR, Lighezan R, Ursoniu S, Craciun AC, Olariu AT, Sprintar SA, Oatis DA, Lupu MA, Mihu AG.   +8 more
europepmc   +1 more source

Steroids for Drug‐Resistant Seizures and Prolonged Stroke‐Like Episode in a Patient With Sturge–Weber Syndrome: A Case Report

Annals of the Child Neurology Society, EarlyView.
ABSTRACT Introduction Sturge–Weber syndrome (SWS) brain involvement has been associated with impairments in the blood–brain barrier (BBB) and microglial activation within involved cortical regions. Acute neurological crises, including seizures, stroke‐like episodes, and/or significant headaches, are common in these patients.
Brenna N. Keam, Fabiola A. Morales‐Vias, Siddharth S. Gupta, Doris D. Lin, Anne M. Comi   +4 more
wiley   +1 more source